Pharmaceutical Care
description
Transcript of Pharmaceutical Care
CASE 7PHARMACEUTICAL CARE
Puspita Octa Sholihah 1408062156
Irfan Imam Taufik 1408062162
Ersi Arviana Ihsan 1408062164
Erlita Nur Arifana 1408062183
Arsy Mulya Dewi 1408062192
Nurul Fatimah H 1408062205
Sonia Suzma Azmi 1408062244
Puput Sri Ardianti 1408062263
Mr Hd, 67 yo, has been consuming ISDN on this year because of his chest pain complaint. This drug firstly bought with doctor’s prescription that combined with β-Blocker. But on these 3 months, he buys those two drugs without any consultation with his doctor. Recently, he felt dizzy, weak, stomachache and bloating. He is coming to your pharmacy and want to buy “sakatonik liver” to increase his stamina and “Kratingdaeng”
VS: BP: 95/70mmHg, HR: 60x/minute, RR: 20x/minute; Hb: 11,7mg/dL
PH: Hyperlipidemia, angina pectoris
DH: ISDN and propanolol, gemfibrozil 2x600mg/day
Lab data: Total Cholesterol: 265; TG: 205; LDL: 100
Habit: likes to consume fried banana
Patient’s Assesment
Name : baby SB
Date and place birth : -
Address : -
Phone : -
Weight: 4,5 kg
Height : -
HR : 30x/minute
BP :
Gender : female
Allergies : penicillin
Medical problem : Chest pain, stomachachae, dizzy, weak, bloating.
Patient History : Hyperlipidemia, Angina PectorisDrugs History : ISDN and Propanolol,
Gemfibrozil 2x600 mg/dayHabit : Likes to consume fried
banana
PRESCRIPTION MEDICATION HISTORY
Name/strength Directions
Start date
Stop date Physician Purpose Effectiven
ess
ISDN - - - - Chest pain
-
Propranolol - - - - Chest pain
-
Non Prescription Medication History
Name/strenght Directions Purpose How often effectiveness
ISDN - Chest pain 3 months -
Propanolol - Chest pain 3 months -
Gemfibrozil - hyperlipidemia
- -
Assessment1. Problem
Subjective : Chest pain, dizzy, weak, stomachache, bloatingObjective :
Vital Signs Value Normal Result
Blood Pressure 95/70 mmHg 120/80 mmHg Hypotension
Heart Rate 60x/minute 60-100x/minute Normal
Respiration rate 20x/minute 16-20x/minute Normal
Laboratory Data Value Normal Result
Haemoglobine 11,7 mg/dl 13-18 mg/dl Anemia
Total Cholesterol 265 mg/dl < 200 mg/dl Hypercholesteremia
Triglyceride 205 mg/dl < 100 mg/dl Hypertriglyceride
LDL 100 mg/dl < 100 mg/dl Hyperlipidemia
Actual and Potential Problem
a. Actual : hypotension
b. Potential : renal disorder, anaphylactic reaction
2. Assessment Clinical Problem :
Chest pain, dizzy, weak, stomachache, bloating, Hypercolesteremia , hyperlipidemia, hypertriglyceride
Diagnosis Pharmaceutical Care:
• Angina Pectoris
Analysis Drug Related Problem (DRPs)Drug therapy problem Cause Present/
Absentnotes
1. Unnecessary drug therapy
• No medical indications• Addiction creational
drug use• Nondrug therapy /more
appropiate• Duplicate therapy• Treating avoidable
adverse reaction
• Absent• Absent
• Absent
• Absent• Absent
2. Wrong drug • Contraindications• Dosage form
inappropiate• Drug not indication for
condition• More effective drug
available dosage to low
• Present• Present• Absent
• Hypotension• Overdose
3. Dosage too low • Frequency inappropiate• Wrong dosage• Incorrect
administration• Drug interaction• Incorrect storage
• Absent• Absent• Absent• Absent• Absent
4. Adverse drug reaction • Allergic reaction• Unsafe drug for patient• Incorrect
administration• Drug interaction• Dosage increased or
decreased too quickly• Undesirable effect
• Absent• Absent• Absent• Absent• Absent
• Absent
Drug therapy problem
Cause Present/ Absent Note
5. Dosage too high • Wrong dose• Frequency
inappropriate• Duration
inappropriate• Drug interaction
• Present• Absent
• Absent
• Gemfibrozil
6. Inappropiate compliance
• Cannot afford drug product
• Cannot swallow or otherwise administer drug
• Does not understand instuctions
• Patient prefers not to take drug
• Absent
• Absent
7. Needs additional drug therapy
• Untreated condition
• Synergistic therapy
• Propilactic therapy
• Absent• Present• Absent
• Antasida for stomache
3. Pharmaceutical Care PlanA. Clinical problem, goal recommendation, and plan of treatment (doses, frequency, and route)
Clinical problem
Goal recommendation
Plan of treatment
Potency Frequency Route
Chest Pain ISDN 2.5 mg May be repeated 5-10 min, not to exceed 3 doses in 15-30
min
sublingual
Dyspepsia Mylanta 5 ml 4x 1 cth/day (2 hr PC and Before Sleep)
Oral
hyperlipidemia
Simvastatin 10 mg 1 x 1 tablet/day before sleep Oral
Anemia Fe Fumarat 150 mg 1 x 1 capsule/ day Oral
B. Monitoringa. monitoring therapeutic effect
Drug / med
Parameter of monitoring
Normal value End point Monitoring frequency
Recommendation
ISDN Chest pain Depend on patient’s physiology condition
Decrease pain
2-10 minutes (DIH)
SublingualNot recommended to combinate with beta blocker inhibited lipid metabolism(medscape.com)
Mylanta - Stomachache
- Bloating
Depend on patient’s physiology condition
Reduce stomachache and bloating
in fasting : 20-60 minutes1 hour after meal : 3 hours(drugs.com)
If necessary
Drug / med
Parameter of monitoring
Normal value End point Monitoring frequency
Recommendation
Simvastatin
Serum lipopotreins
Depend on patient’s
physiology condition
Decreasing of
lipoproteins
2-5 days VLDL
decreases(drug.com)
Before sleeping
Fe Fumarate
Hb Depend on patient’s
physiology condition
Increasing Hb
2-4 weeks Hb value
increases
Life style modification
b. Monitoring ADRDrug Monitoring ADR
ISDN - Severe Hypotension (infrequent)- Pallor - Dizziness- Nausea vomiting- Headache (most common)- Bradycardia- Postural hypotention- WeaknessDIH (edition 17, 2008-2009)
Mylanta - Diarhea- Increasing clearance
Simvastatin - 1-10 % abdominal pain- < 1 % myopathy
Fe Fumarat - constipation
CIE (Counseling, Information, and Education)Drug Dose
sUse Frequency storage Adverse
Effect
ISDN 2.5 mg
sublingual
May be repeated 5-10 min, not to exceed 3 doses in 15-
30 min
Room temperature
hypotension
Mylanta 5 ml oral 4 x 1 cth/day (2 hours PC and before
sleep)
Room temperature
-Diarhea- Increasing clearance
Simvastatin
10 mg oral 1 x 1 tablets/day before sleep
Room temperature
- 1-10 % abdominal pain- < 1 % myopathy
Fe Fumarat
150 mg
oral 1 x 1 capsule/day Room temperature
- constipation
LIFE STYLE MODIFICATION
Drug Contraindication Sakatonic liver composition : Vitamine B1, B2, B6, Vitamine C, Nicotinamide, Ca
Pantothenate, Na Hypophospite, Mn Sulfat, Fe Sulfat
Kratingdaeng : Cafein, Taurin, Inositol , Niacinamide , Pyridoxine HCL, Dexpanthenol, Cianocobalamine
Effect of Calcium : increasing heart work by contriction the artherie and decline supply oxigen to heart muscle with coronary artherie plasma
Effect of Cafein : increasing heart work, increasing gastric acid, increasing tryglyceride
References Drugs.com
Medscape.com
Drug Information Handbook 17th edition
MIMS.com
Pubmed.com